Closed
Exercise
Calculated transaction value
$1.19M

Paolini John F. Chief Medical Officer

Transaction date Oct 30, 2026
Public filing date Nov 3, 2026
Filing lag Filed 4 days later

KNSA daily price context

Close on/before transaction
$92.24 Oct 30, 2026
First close after public filing
$96.12 Nov 4, 2026
Return after filing · so far
-2.35% Through Nov 6, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Class A Ordinary Share
Quantity / price
38,545 shares @ $30.93
SEC ownership
Direct
Transaction code
M
Form
4
Filing identifier
0001741533-26-000012
Filing cohort

Transactions in this filing

Showing 15 of 18
Trades
18
Issuers
1
Estimated value
$11.24M
Buys / sales
0 / 10
Transactions reported in the same official filing
Issuer Transaction Traded Value
Kiniksa Pharmaceuticals International, Plc KNSA Sale Nov 2, 2026 $83.04K
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Nov 2, 2026 $199.65K
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Nov 2, 2026 $214.29K
Kiniksa Pharmaceuticals International, Plc KNSA Sale Nov 2, 2026 $1.57M
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Nov 2, 2026 $0
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Nov 2, 2026 $0
Kiniksa Pharmaceuticals International, Plc KNSA Sale Nov 2, 2026 $66.24K
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Oct 30, 2026 $699.63K
Kiniksa Pharmaceuticals International, Plc KNSA Sale Oct 30, 2026 $383.88K
Kiniksa Pharmaceuticals International, Plc KNSA Sale Oct 30, 2026 $3.85M
Kiniksa Pharmaceuticals International, Plc KNSA Current Exercise Oct 30, 2026 $1.19M
Kiniksa Pharmaceuticals International, Plc KNSA Sale Oct 30, 2026 $210.69K
Kiniksa Pharmaceuticals International, Plc KNSA Sale Oct 30, 2026 $642.44K
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Oct 30, 2026 $0
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Oct 30, 2026 $0